History
Avascular necrosis is a disease in which bone tissue dies because the bone does not receive an adequate blood supply. The name osteonecrosis is also widely used with the same meaning. In the past, even when doctors saw someone whose joint suddenly broke down and whose pain grew severe, it was difficult to directly confirm that the cause was a "disturbance of blood flow within the bone." This is because early changes are not easily seen on X-ray alone.
However, as imaging technology advanced, the understanding of the disease changed greatly. As magnetic resonance imaging (MRI) came into wide use, it became possible to confirm early that necrosis within the bone had already begun, even in joints that looked normal from the outside. This change also influenced treatment strategies. In the past, the conclusion that "a joint replacement is needed" was often reached only after the pain had worsened and the joint surface had collapsed, but now treatments that detect the disease before the joint collapses (the precollapse stage) and aim to slow its progression or preserve the joint are actively discussed.
In recent research, there have been more attempts to view the treatment of avascular necrosis not merely as a matter of "symptom relief," but to systematically organize the evidence on which treatment, chosen at which point, can delay the collapse of the joint. In particular, because cases such as avascular necrosis of the femoral head in the hip often occur in younger age groups and can affect joint function for a lifetime, the concepts of early diagnosis and stage-based treatment are being emphasized more.
Causes
The core cause of avascular necrosis is "a reduction or blockage of blood flow into the bone." As a result, bone cells die because they cannot receive oxygen and nutrients, the bone weakens over time and microfractures accumulate, and eventually the bone that supported the joint surface can collapse. The causes are easiest to understand when broadly divided into traumatic and nontraumatic. Traumatic cases are those in which blood vessels are directly damaged by an accident, such as a fracture or joint dislocation. For example, a femoral neck fracture or hip dislocation can damage the blood vessels supplying the femoral head.
Nontraumatic cases are those in which a blood flow disturbance occurs even without any obvious major accident; high-dose or long-term steroid (corticosteroid) use and heavy drinking are known as representative risk factors. In addition, the condition may be associated with certain blood disorders (e.g., sickle cell disease), autoimmune diseases, organ transplantation, radiation therapy, chemotherapy, and diving-related high-pressure exposure (related to decompression sickness).
Recent research emphasizes that choosing treatment according to the cause is important. In particular, in avascular necrosis of the femoral head in the hip, if the lesion is still small and the joint surface has not yet collapsed, joint-preserving surgery (e.g., core decompression) is considered, while if collapse and arthritis have already progressed, total hip arthroplasty (THA) can be a realistic option.
Genetic Epidemiology
Avascular necrosis is not a typical hereditary disease, but because "even with the same steroid use or similar drinking, some people develop it and others do not," the possibility that individual constitutional vulnerability plays a role has been raised consistently. In fact, factors such as blood clotting tendency, fat metabolism, inflammatory response, and vascular endothelial function may be intertwined in a complex way. However, the conclusion that is easy for the general public to understand is roughly that "rather than genes being the cause, individuals may differ in their sensitivity to various risk factors."
At present, there is no standard test in clinical practice that screens for or predicts the risk of avascular necrosis through specific genetic testing. Therefore, what matters more than family history are clinical risk factors such as history of steroid use, drinking habits, history of trauma, and comorbidities.
Recent research emphasizes that avascular necrosis commonly occurs even in young adults and, because it often involves the femoral head, can greatly affect daily functioning and working life. It is more practically helpful to explain genetic epidemiology with the goal of "recognizing and controlling an individual's risk factors earlier."
General Epidemiology
Avascular necrosis is known to be diagnosed most often in people in their 30s to 50s, and there are reports that it is more common in men than in women. The most commonly affected site is the end of the femur, particularly the femoral head that forms the hip joint. The reason is that the femoral head is a weight-bearing structure, so even small injuries tend to accumulate, and its blood supply route may also be relatively vulnerable. Avascular necrosis may seem like a disease that occurs in only one site, but in reality it is not uncommon for both hip joints to be affected together or for several joints to be affected at the same time.
Because of these characteristics, an "asymptomatic lesion" is sometimes found on the opposite side while one painful hip is being examined. Recent research repeatedly mentions that avascular necrosis of the femoral head in the hip is one of the important causes of joint replacement surgery in young adults.
The epidemiologically important point is that it is "a cause that must be differentiated in hip pain at a young age." If it is dismissed as simple muscle pain or a back problem, it may be discovered only at the stage of joint surface collapse, and treatment options may be reduced.
Pathogenesis
The pathogenesis of avascular necrosis can be understood as the sequence "blood flow interruption → bone cell death → structural weakening → collapse under weight bearing." When blood flow decreases, the bone marrow and bone cells inside the bone fall into a state of oxygen deprivation, and the sensitive cells are damaged first. In the damaged area, the body tries to recover by forming new blood vessels (angiogenesis), clearing away the damaged tissue, and forming new bone, but if the extent of the damage is large or weight bearing continues, recovery cannot keep pace.
As a result, microfractures form at the boundary between the necrotic area and the normal area, and as the bone just beneath the joint surface (subchondral bone) weakens, imaging findings such as the "crescent sign" may appear. If progression is not stopped at this stage, the joint surface collapses, which then leads to secondary osteoarthritis, greatly increasing pain and functional impairment.
Recent research has systematically analyzed the finding that, in the precollapse stage, core decompression can help relieve pain and improve function, and that short-term functional measures may be better especially when biological augmentation (e.g., bone marrow aspirate concentrate (BMAC), platelet-rich plasma (PRP)) is used together. However, because studies differ on whether it definitely reduces radiographic progression or conversion to joint replacement, the research concludes that factors such as lesion size and stage, cause, and patient age must be considered together.
Symptoms
Avascular necrosis may cause no symptoms at first. For this reason, it is sometimes found incidentally while a person with risk factors is undergoing tests. When symptoms begin to appear, the most common form is "joint pain." When the femoral head is affected, it is often felt as groin (inguinal) pain or buttock pain, and the pain may also feel as if it spreads toward the thigh or knee. Early pain usually tends to worsen when weight is placed on the joint, such as when walking, climbing stairs, or standing for a long time, and to improve with rest.
As it progresses, the pain becomes more frequent, movement decreases, and limping may develop. With further progression, it may change into rest pain or night pain, hurting even at rest or at night. In addition, because it can also occur in other joints such as the shoulder, knee, and ankle, it sometimes appears in the form of "several joints hurting in turn without a clear cause."
In particular, when there are systemic risk factors such as steroid use, heavy drinking, or blood disorders, it is important to keep multiple lesions in mind. Even during a period without symptoms, if risk factors are present, it is advisable to consider early evaluation.
Signs
The signs observed on examination vary depending on the site of the lesion, but in avascular necrosis of the hip, a reduced range of motion of the hip joint is a relatively common finding. In particular, internal rotation is often the first to be limited or to provoke pain. As the person avoids putting weight on the leg because of pain, the gait changes and a limp may appear. When the disease progresses and the joint surface collapses, functional decline such as leg length discrepancy, worsening restriction of movement, and atrophy of the muscles around the joint may become more evident.
Signs seen on imaging are also important. In the early stage, X-rays may appear normal, but MRI detects changes such as the extent of necrosis and bone marrow edema relatively sensitively. As the disease progresses, findings such as sclerosis, cysts, the crescent sign, femoral head collapse, and joint space narrowing appear on X-ray or CT.
In other words, the certainty of the diagnosis increases when the signs from "examination findings + imaging findings" fit together. At this stage, even examination alone provides more clues that "a structural problem of the joint itself is suspected."
Screening
The key to screening so that avascular necrosis is not missed is to think of "risk factors + persistent joint pain" together. Risk factors such as steroid use (dose and duration), heavy drinking, a history of trauma such as hip dislocation or fracture, blood disorders, and diving-related high-pressure exposure are checked, and it is examined whether there is joint pain temporally linked to them. If the symptoms are concentrated in the hip, worsen with walking, and persist for several weeks or more, it is difficult to regard them as simple muscle pain alone.
In such cases, the core of the screening strategy is to start with plain X-rays, but to consider MRI if suspicion is strong even when the initial X-ray is normal. In particular, if one side is suspected, it can be useful to evaluate the opposite side as well.
Recent research emphasizes that, because joint-preserving treatment is expected to be more effective in the precollapse stage, the approach of "confirming early with MRI and determining the stage (staging)" at the screening step affects treatment choice and prognosis.
Diagnosis
The diagnosis of avascular necrosis is made by combining the medical history and physical examination with imaging tests. In the medical history, identifying risk factors is most important. In the physical examination, pain-provoking movements, limitation of range of motion, and the presence of limping are evaluated. Imaging tests are easiest to understand when thought of step by step. First, X-rays are taken to check for other causes (fractures, severe arthritis, etc.) and to see whether there are characteristic findings of advanced avascular necrosis (crescent sign, collapse, etc.). However, X-rays may be normal in the early stage.
Second, MRI can detect early lesions most sensitively and is regarded as the key test for early diagnosis. CT can be helpful for looking more precisely at structural changes in the bone or the degree of collapse, and a bone scan may be used as an adjunct when evaluating lesions at multiple sites. Another important part of diagnosis is staging. Because in actual treatment "whether the joint surface has now collapsed" is a very major criterion, several staging systems (Ficat, ARCO, etc.) are used to evaluate whether it is the precollapse stage or whether collapse has already begun.
Rarely, when the diagnosis is ambiguous, it can be confirmed by tissue examination (biopsy), but imaging is generally sufficient. Accurately determining the stage through early diagnosis is the key to deciding the direction of treatment.
Treatment
There are two goals in the treatment of avascular necrosis. The first is to reduce pain and maintain function, and the second is to delay or prevent collapse of the joint surface where possible. Therefore, treatment varies according to the stage and extent of the lesion and the patient's age and activity level. In the early stage (precollapse stage), conservative treatment such as walking aids to reduce weight bearing, pain control, and stretching may be performed, but in many cases this alone has difficulty stopping progression. Therefore, joint-preserving surgery is discussed. The representative surgery is core decompression.
This is a method of creating a channel in the bone to lower the pressure inside the bone and to aid the recovery of blood flow and bone regeneration. Recent research concludes that, compared with core decompression alone, function scores and pain may be better for a certain period when it is combined with biological augmentation (e.g., PRP, BMAC, stem cell-based therapy, etc.). When the disease progresses and the joint surface collapses or arthritis develops, total hip arthroplasty (THA) can be the most reliable way to relieve pain and restore function.
In particular, because a joint replacement may become necessary even at a young age in avascular necrosis, "when to perform surgery" and "how long to delay it if possible" become important considerations in the treatment strategy. The treatment choice is decided by comprehensively considering the stage, cause, and patient's condition.
Prognosis
The prognosis of avascular necrosis varies greatly depending on "which bone is affected," "how large the extent of necrosis is," and "whether collapse of the joint surface has begun." If the lesion is small and is found in the precollapse stage, the possibility of slowing progression is relatively high. Conversely, if the crescent sign is already visible or the joint surface has begun to collapse, the likelihood of progression to arthritis over time increases. To describe the prognosis realistically, if it is not treated or is treated late, the pain gradually worsens and, as the joint collapses, a joint replacement is eventually needed in many cases.
However, not all patients worsen at the same rate, and there are differences depending on the cause (whether traumatic or nontraumatic), control of risk factors (whether steroids can be tapered, control of drinking, etc.), the location and size of the lesion, and the timing of treatment.
Recent research shows that when biological therapy is added to core decompression in the precollapse stage, function and pain may be better for a certain period, but concludes that the quality of evidence on whether it definitely reduces conversion to joint replacement in the long term is not uniformly high and that there are large differences between studies. Therefore, the most important direction for prognosis is "detecting it early, choosing the available treatment, and controlling risk factors."
Prevention
Avascular necrosis can be completely prevented in some cases, but there are also unavoidable situations. Traumatic avascular necrosis is difficult to prevent completely because the accident itself is hard to avoid, but when a fracture or dislocation occurs, it is important to minimize blood vessel damage through prompt and appropriate treatment. The most important thing in preventing nontraumatic avascular necrosis is managing risk factors. Steroids are very useful drugs for diseases that truly require them, but it is important to use the lowest effective dose possible and, when long-term high-dose use is unavoidable, to quickly recognize signals such as joint pain or changes in gait.
Because heavy drinking is a modifiable risk factor, reducing alcohol consumption can be helpful. In addition, in conditions that may raise the risk, such as blood disorders or autoimmune diseases, a practical method of prevention is to have new joint pain evaluated rather than dismissing it as simple pain.
Recent research emphasizes strategies that bring forward the timing of diagnosis and treatment in order to increase the effectiveness of joint-preserving treatment at an early stage. Therefore, the main point of prevention can be summarized as "reduce risk factors, and seek early evaluation when warning signs appear." Not only "prevention that eliminates the disease" but also "prevention that detects it before collapse and slows its progression" are important together.